世界の脊髄性筋萎縮症遺伝子検出市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Spinal Muscular Atrophy Genetic Detection Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4895
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症遺伝子検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、発症前検査）、用途別市場規模（病院、クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・脊髄性筋萎縮症遺伝子検出の市場動向
・企業の競争状況、市場シェア
・脊髄性筋萎縮症遺伝子検出の種類別市場規模と予測2016-2027（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、発症前検査）
・脊髄性筋萎縮症遺伝子検出の用途別市場規模と予測2016-2027（病院、クリニック、診断センター）
・脊髄性筋萎縮症遺伝子検出の北米市場規模2016-2027（アメリカ、カナダ）
・脊髄性筋萎縮症遺伝子検出の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・脊髄性筋萎縮症遺伝子検出のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・脊髄性筋萎縮症遺伝子検出の中南米市場規模2016-2027（メキシコ、ブラジル）
・脊髄性筋萎縮症遺伝子検出の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（United Gene Group、Berrygenomics、Sanvalley、Microread、Genecore）
・結論

A detection method for Spinal Muscular Atrophy

Market Analysis and Insights: Global Spinal Muscular Atrophy Genetic Detection Market
The global Spinal Muscular Atrophy Genetic Detection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal Muscular Atrophy Genetic Detection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal Muscular Atrophy Genetic Detection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal Muscular Atrophy Genetic Detection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal Muscular Atrophy Genetic Detection market.

Global Spinal Muscular Atrophy Genetic Detection Scope and Market Size
Spinal Muscular Atrophy Genetic Detection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal Muscular Atrophy Genetic Detection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear

Segment by Application
Hospital
Clinic
Diagnostic Center

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
United Gene Group
Berrygenomics
Sanvalley
Microread
Genecore

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Genetic Detection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Genetic Detection Market Perspective (2016-2027)
2.2 Spinal Muscular Atrophy Genetic Detection Growth Trends by Regions
2.2.1 Spinal Muscular Atrophy Genetic Detection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal Muscular Atrophy Genetic Detection Historic Market Share by Regions (2016-2021)
2.2.3 Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Regions (2022-2027)
2.3 Spinal Muscular Atrophy Genetic Detection Industry Dynamic
2.3.1 Spinal Muscular Atrophy Genetic Detection Market Trends
2.3.2 Spinal Muscular Atrophy Genetic Detection Market Drivers
2.3.3 Spinal Muscular Atrophy Genetic Detection Market Challenges
2.3.4 Spinal Muscular Atrophy Genetic Detection Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue (2016-2021)
3.1.2 Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Players (2016-2021)
3.2 Global Spinal Muscular Atrophy Genetic Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy Genetic Detection Revenue
3.4 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Genetic Detection Revenue in 2020
3.5 Spinal Muscular Atrophy Genetic Detection Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy Genetic Detection Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy Genetic Detection Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Type (2016-2021)
4.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2022-2027)

5 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Application (2016-2021)
5.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Spinal Muscular Atrophy Genetic Detection Market Size (2016-2027)
6.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type
6.2.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021)
6.2.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027)
6.2.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2027)
6.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application
6.3.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021)
6.3.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027)
6.3.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2027)
6.4 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country
6.4.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021)
6.4.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size (2016-2027)
7.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021)
7.2.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027)
7.2.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2027)
7.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021)
7.3.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027)
7.3.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2027)
7.4 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021)
7.4.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size (2016-2027)
8.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size (2016-2027)
9.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021)
9.2.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027)
9.2.3 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2027)
9.3 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021)
9.3.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027)
9.3.3 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2027)
9.4 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021)
9.4.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size (2016-2027)
10.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 United Gene Group
11.1.1 United Gene Group Company Details
11.1.2 United Gene Group Business Overview
11.1.3 United Gene Group Spinal Muscular Atrophy Genetic Detection Introduction
11.1.4 United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
11.1.5 United Gene Group Recent Development
11.2 Berrygenomics
11.2.1 Berrygenomics Company Details
11.2.2 Berrygenomics Business Overview
11.2.3 Berrygenomics Spinal Muscular Atrophy Genetic Detection Introduction
11.2.4 Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
11.2.5 Berrygenomics Recent Development
11.3 Sanvalley
11.3.1 Sanvalley Company Details
11.3.2 Sanvalley Business Overview
11.3.3 Sanvalley Spinal Muscular Atrophy Genetic Detection Introduction
11.3.4 Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
11.3.5 Sanvalley Recent Development
11.4 Microread
11.4.1 Microread Company Details
11.4.2 Microread Business Overview
11.4.3 Microread Spinal Muscular Atrophy Genetic Detection Introduction
11.4.4 Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
11.4.5 Microread Recent Development
11.5 Genecore
11.5.1 Genecore Company Details
11.5.2 Genecore Business Overview
11.5.3 Genecore Spinal Muscular Atrophy Genetic Detection Introduction
11.5.4 Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
11.5.5 Genecore Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Spinal Muscular Atrophy Genetic Detection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Regions (2016-2021)
Table 11. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Spinal Muscular Atrophy Genetic Detection Market Share by Regions (2022-2027)
Table 13. Spinal Muscular Atrophy Genetic Detection Market Trends
Table 14. Spinal Muscular Atrophy Genetic Detection Market Drivers
Table 15. Spinal Muscular Atrophy Genetic Detection Market Challenges
Table 16. Spinal Muscular Atrophy Genetic Detection Market Restraints
Table 17. Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players (2016-2021)
Table 19. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2020)
Table 20. Ranking of Global Top Spinal Muscular Atrophy Genetic Detection Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Spinal Muscular Atrophy Genetic Detection Product Solution and Service
Table 24. Date of Enter into Spinal Muscular Atrophy Genetic Detection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2016-2021)
Table 28. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Spinal Muscular Atrophy Genetic Detection Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Application (2016-2021)
Table 32. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2022-2027) & (US$ Million)
Table 64. United Gene Group Company Details
Table 65. United Gene Group Business Overview
Table 66. United Gene Group Spinal Muscular Atrophy Genetic Detection Product
Table 67. United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021) & (US$ Million)
Table 68. United Gene Group Recent Development
Table 69. Berrygenomics Company Details
Table 70. Berrygenomics Business Overview
Table 71. Berrygenomics Spinal Muscular Atrophy Genetic Detection Product
Table 72. Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021) & (US$ Million)
Table 73. Berrygenomics Recent Development
Table 74. Sanvalley Company Details
Table 75. Sanvalley Business Overview
Table 76. Sanvalley Spinal Muscular Atrophy Genetic Detection Product
Table 77. Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021) & (US$ Million)
Table 78. Sanvalley Recent Development
Table 79. Microread Company Details
Table 80. Microread Business Overview
Table 81. Microread Spinal Muscular Atrophy Genetic Detection Product
Table 82. Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021) & (US$ Million)
Table 83. Microread Recent Development
Table 84. Genecore Company Details
Table 85. Genecore Business Overview
Table 86. Genecore Spinal Muscular Atrophy Genetic Detection Product
Table 87. Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2016-2021) & (US$ Million)
Table 88. Genecore Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Genetic Detection Market Share by Type: 2020 VS 2027
Figure 2. Genetic Screening Features
Figure 3. Reproductive Genetic Testing Features
Figure 4. Diagnostic Test Features
Figure 5. Gene carrier Test Features
Figure 6. Testing Before Symptoms Appear Features
Figure 7. Global Spinal Muscular Atrophy Genetic Detection Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Diagnostic Center Case Studies
Figure 11. Spinal Muscular Atrophy Genetic Detection Report Years Considered
Figure 12. Global Spinal Muscular Atrophy Genetic Detection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Spinal Muscular Atrophy Genetic Detection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Spinal Muscular Atrophy Genetic Detection Market Share by Regions: 2020 VS 2027
Figure 15. Global Spinal Muscular Atrophy Genetic Detection Market Share by Regions (2022-2027)
Figure 16. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players in 2020
Figure 17. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue in 2020
Figure 19. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2016-2021)
Figure 20. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2022-2027)
Figure 21. North America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2016-2027)
Figure 23. North America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2016-2027)
Figure 24. North America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2016-2027)
Figure 25. United States Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Type (2016-2027)
Figure 29. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Application (2016-2027)
Figure 30. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Country (2016-2027)
Figure 31. Germany Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Share by Region (2016-2027)
Figure 41. China Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2016-2027)
Figure 49. Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2016-2027)
Figure 50. Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2016-2027)
Figure 51. Mexico Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Share by Country (2016-2027)
Figure 57. Turkey Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. United Gene Group Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
Figure 61. Berrygenomics Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
Figure 62. Sanvalley Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
Figure 63. Microread Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
Figure 64. Genecore Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5351 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌシネルセン、オナセムノゲンアベパルボベック）、用途別市場規模（タイプ1SMA、タイプ2 SMA、その他）、主要地域別市場規...

世界の球脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6018 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、球脊髄性筋萎縮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト）、用途別市場規模（病院、整形外科クリニック、外来手術センター）、主要...

世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年）

Global Multiple System Atrophy Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4535 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、多系統萎縮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンレ-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）、用途別市場規模（病院、クリニ...

世界のデュシェンヌ型筋ジストロフィー(DMD)治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Duchenne Muscular Dystrophy (DMD) Market Size, Status and Forecast 2021-2027
QFJ1-5718 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、デュシェンヌ型筋ジストロフィー(DMD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エテプリルセン、デフラザコート、アタルレン）、用途別市場規模（病院、診療所、ホームケア）、主要地域別市場規...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-4248 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（...

世界のサラセミア遺伝子検出市場規模・現状・予測（2021年-2027年）

Global Thalassemia Gene Detection Market Size, Status and Forecast 2021-2027
QFJ1-4949 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、サラセミア遺伝子検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、発症前検査）、用途別市場規模（病院、クリニック、診断センター）、主...

世界の才能遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Talent Genetic Testing Market Size, Status and Forecast 2021-2027
QFJ1-4932 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、才能遺伝子検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、遺伝子保因者検査、生殖遺伝子検査）、用途別市場規模（病院、クリニック、診断センター）、主要地域別市場規模（北米、アメ...

世界の遺伝性難聴遺伝子検出市場規模・現状・予測（2021年-2027年）

Global Hereditary Deafness Gene Detection Market Size, Status and Forecast 2021-2027
QFJ1-4308 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、遺伝性難聴遺伝子検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子検査、生殖遺伝子検査、診断検査、遺伝子保有者検査、症状前検査）、用途別市場規模（病院、クリニック、診断センター）、主要地域別市...

世界の遺伝毒性試験市場規模・現状・予測（2021年-2027年）

Global Genetic Toxicology Testing Market Size, Status and Forecast 2021-2027
QFJ1-5179 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、遺伝毒性試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（試薬＆消耗品、分析、サービス）、用途別市場規模（医療産業（製薬＆バイオテクノロジー）、食品産業、化粧品産業、農業＆化学産業）、主要地域別市場...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年） Spinal Muscular Atrophy (SMA), also known as spinal muscular atrophy, is a type of disease in which the degeneration of motor neurons in the anterior horn of the spinal cord leads to muscle weakness and muscular atrophy.The Spinal muscular atrophy drugs Can effectively alleviate the symptoms of the …
世界の才能遺伝子検査市場規模・現状・予測（2021年-2027年） A method for detecting children's talent Market Analysis and Insights: Global Talent Genetic Testing Market The global Talent Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in a…
世界のダウンシンドローム遺伝子検査市場規模・現状・予測（2021年-2027年） A method to detect Down syndrome Market Analysis and Insights: Global Down Syndrome Genetic Testing Market The global Down Syndrome Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accurac…
世界のフェニルケトン尿遺伝子検査市場規模・現状・予測（2021年-2027年） A detection method for Phenylketonuria Market Analysis and Insights: Global Phenylketonuria Genetic Testing Market The global Phenylketonuria Genetic Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standa…
世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年） Spinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy through the gene therapy drug called Zolgensma…